FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011648035> ?p ?o ?g. }

• W2011648035 endingPage "705" @default.
• W2011648035 startingPage "694" @default.
• W2011648035 abstract "The main aim of drug targeting was to increase the selectivity and efficacy of drugs at the infected site and to reduce the toxicity of biotechnological entities on other parts of the body. In the present study, we selected the triple therapy (amoxicillin, clarithromycin and omeprazole) due to its synergic and additive effects, which could drastically reduce the effective dose required for the complete eradication of Helicobacter pylori and prevent the development of antibiotic resistance. The gliadin nanoparticles (GNP) vis-à-vis lectin-conjugated gliadin nanoparticles (LGNP) of triple therapy were prepared by a desolvation method and evaluated for percent entrapment efficiency, percent yield, in vitro drug release study and mucoadhesion properties of formulations. The maximum percent entrapment efficiency of formulations was in the range of 65–85%. The percent yield of formulation was about 84 ± 2.68%. The maximum percent cumulative release of all the three drugs from formulations was in the range of 22–76%. The specificity of lectin-conjugated particles was assessed by an in vitro agglutination assay method. The developed formulation was also assessed for in vitro antibacterial study, in vivo clearance efficacy and histopathological evaluation of formulations. In the in vitro antibacterial study, the LGNP with triple therapy showed a 94.83% eradication rate that is 7.4% more than that of GNP with triple therapy (88.28%) and about 16% more than that of the plain triple therapy (P < 0.001). The targeted lectin-conjugated formulations exhibited a superior in vivo clearance efficacy when compared to the non-conjugated formulations and plain drugs." @default.
• W2011648035 created "2016-06-24" @default.
• W2011648035 creator A5044553697 @default.
• W2011648035 creator A5050922784 @default.
• W2011648035 creator A5058145331 @default.
• W2011648035 creator A5089719246 @default.
• W2011648035 date "2008-01-01" @default.
• W2011648035 modified "2023-10-01" @default.
• W2011648035 title "Triple therapy-based targeted nanoparticles for the treatment of<i>Helicobacter pylori</i>" @default.
• W2011648035 cites W1555922620 @default.
• W2011648035 cites W1766937781 @default.
• W2011648035 cites W195414877 @default.
• W2011648035 cites W1966273481 @default.
• W2011648035 cites W1977415169 @default.
• W2011648035 cites W2000392212 @default.
• W2011648035 cites W2001130388 @default.
• W2011648035 cites W2015615249 @default.
• W2011648035 cites W2019137217 @default.
• W2011648035 cites W2020312222 @default.
• W2011648035 cites W2024854627 @default.
• W2011648035 cites W2029093615 @default.
• W2011648035 cites W2029896504 @default.
• W2011648035 cites W2035930633 @default.
• W2011648035 cites W2038248809 @default.
• W2011648035 cites W2042132872 @default.
• W2011648035 cites W2047988015 @default.
• W2011648035 cites W2057340503 @default.
• W2011648035 cites W2057432968 @default.
• W2011648035 cites W2066839030 @default.
• W2011648035 cites W2067648274 @default.
• W2011648035 cites W2072538393 @default.
• W2011648035 cites W2091470606 @default.
• W2011648035 cites W2092414932 @default.
• W2011648035 cites W2094487294 @default.
• W2011648035 cites W2102374831 @default.
• W2011648035 cites W2110477578 @default.
• W2011648035 cites W2119639771 @default.
• W2011648035 cites W2136371211 @default.
• W2011648035 cites W2142693274 @default.
• W2011648035 cites W2143107875 @default.
• W2011648035 cites W2152472522 @default.
• W2011648035 cites W2158362878 @default.
• W2011648035 cites W2163250993 @default.
• W2011648035 cites W3144999141 @default.
• W2011648035 cites W4302399697 @default.
• W2011648035 cites W55834304 @default.
• W2011648035 cites W59104685 @default.
• W2011648035 doi "https://doi.org/10.1080/10611860802295839" @default.
• W2011648035 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18982518" @default.
• W2011648035 hasPublicationYear "2008" @default.
• W2011648035 type Work @default.
• W2011648035 sameAs 2011648035 @default.
• W2011648035 citedByCount "32" @default.
• W2011648035 countsByYear W20116480352012 @default.
• W2011648035 countsByYear W20116480352013 @default.
• W2011648035 countsByYear W20116480352014 @default.
• W2011648035 countsByYear W20116480352015 @default.
• W2011648035 countsByYear W20116480352017 @default.
• W2011648035 countsByYear W20116480352018 @default.
• W2011648035 countsByYear W20116480352019 @default.
• W2011648035 countsByYear W20116480352020 @default.
• W2011648035 countsByYear W20116480352021 @default.
• W2011648035 countsByYear W20116480352022 @default.
• W2011648035 countsByYear W20116480352023 @default.
• W2011648035 crossrefType "journal-article" @default.
• W2011648035 hasAuthorship W2011648035A5044553697 @default.
• W2011648035 hasAuthorship W2011648035A5050922784 @default.
• W2011648035 hasAuthorship W2011648035A5058145331 @default.
• W2011648035 hasAuthorship W2011648035A5089719246 @default.
• W2011648035 hasConcept C126322002 @default.
• W2011648035 hasConcept C150903083 @default.
• W2011648035 hasConcept C185592680 @default.
• W2011648035 hasConcept C202751555 @default.
• W2011648035 hasConcept C207001950 @default.
• W2011648035 hasConcept C2776409635 @default.
• W2011648035 hasConcept C2776962512 @default.
• W2011648035 hasConcept C2777396551 @default.
• W2011648035 hasConcept C2779708577 @default.
• W2011648035 hasConcept C501593827 @default.
• W2011648035 hasConcept C55493867 @default.
• W2011648035 hasConcept C71924100 @default.
• W2011648035 hasConcept C86803240 @default.
• W2011648035 hasConcept C98274493 @default.
• W2011648035 hasConceptScore W2011648035C126322002 @default.
• W2011648035 hasConceptScore W2011648035C150903083 @default.
• W2011648035 hasConceptScore W2011648035C185592680 @default.
• W2011648035 hasConceptScore W2011648035C202751555 @default.
• W2011648035 hasConceptScore W2011648035C207001950 @default.
• W2011648035 hasConceptScore W2011648035C2776409635 @default.
• W2011648035 hasConceptScore W2011648035C2776962512 @default.
• W2011648035 hasConceptScore W2011648035C2777396551 @default.
• W2011648035 hasConceptScore W2011648035C2779708577 @default.
• W2011648035 hasConceptScore W2011648035C501593827 @default.
• W2011648035 hasConceptScore W2011648035C55493867 @default.
• W2011648035 hasConceptScore W2011648035C71924100 @default.
• W2011648035 hasConceptScore W2011648035C86803240 @default.
• W2011648035 hasConceptScore W2011648035C98274493 @default.
• W2011648035 hasIssue "9" @default.

• next